The Diamidine Diminazene Aceturate Is a Substrate for the High-Affinity Pentamidine Transporter: Implications for the Development of High Resistance Levels in Trypanosomes
- 24 March 2011
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET)
- Vol. 80 (1), 110-116
- https://doi.org/10.1124/mol.111.071555
Abstract
African trypanosomiasis is a disease of humans and livestock in many areas south of the Sahara. Resistance to the few existing drugs is a major impediment to the control of these diseases, and we investigated how resistance to the main veterinary drug diminazene aceturate correlates with changes in drug transport in resistant strains. The strain tbat1(−/−), lacking the TbAT1/P2 aminopurine transporter implicated previously in diminazene transport, was adapted to higher levels of diminazene resistance. The resulting cell line was designated ABR and was highly cross-resistant to other diamidines and moderately resistant to cymelarsan. Procyclic trypanosomes were shown to be a convenient model to study diamidine uptake in Trypanosoma brucei brucei given the lack of TbAT1/P2 and a 10-fold higher activity of the high-affinity pentamidine transporter (HAPT1). Diminazene could be transported by HAPT1 in procyclic trypanosomes. This drug transport activity was lacking in the ABR line, as reported previously for the pentamidine-adapted line B48. The Km for diminazene transport in bloodstream tbat1(−/−) trypanosomes was consistent with uptake by HAPT1. Diminazene transport in ABR and B48 cells was reduced compared with tbat1(−/−), but their resistance phenotype was different: B48 displayed higher levels of resistance to pentamidine and the melaminophenyl arsenicals, whereas ABR displayed higher resistance to diminazene. These results establish a loss of HAPT1 function as a contributing factor to diminazene resistance but equally demonstrate for the first time that adaptations other than those determining the initial rates of drug uptake contribute to diamidine and arsenical resistance in African trypanosomes.Keywords
This publication has 31 references indexed in Scilit:
- Trypanocidal Furamidine Analogues: Influence of Pyridine Nitrogens on Trypanocidal Activity, Transport Kinetics, and Resistance PatternsAntimicrobial Agents and Chemotherapy, 2011
- A fluorescence-based assay for the uptake of CPD0801 (DB829) by African trypanosomesMolecular and Biochemical Parasitology, 2010
- Symmetrical choline-derived dications display strong anti-kinetoplastid activityJournal of Antimicrobial Chemotherapy, 2010
- NECT Is Next: Implementing the New Drug Combination Therapy for Trypanosoma brucei gambiense Sleeping SicknessPLoS Neglected Tropical Diseases, 2010
- New Benzophenone-Derived Bisphosphonium Salts as Leishmanicidal Leads Targeting Mitochondria through Inhibition of Respiratory Complex IIJournal of Medicinal Chemistry, 2010
- Predictive Computational Models of Substrate Binding by a Nucleoside TransporterPublished by Elsevier BV ,2009
- Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trialThe Lancet, 2009
- The Mitochondrion Is a Site of Trypanocidal Action of the Aromatic Diamidine DB75 in Bloodstream Forms of Trypanosoma bruceiAntimicrobial Agents and Chemotherapy, 2008
- Diphenyl Furans and Aza Analogs: Effects of Structural Modification on In Vitro Activity, DNA Binding, and Accumulation and Distribution in TrypanosomesAntimicrobial Agents and Chemotherapy, 2007
- Drugs and drug resistance in African trypanosomiasisDrug Resistance Updates, 2007